Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.
Lars RejnmarkElvira O GosmanovaAliya A KhanNoriko MakitaYasuo ImanishiYasuhiro TakeuchiStuart SpragueDolores M ShobackLynn KohlmeierMishaela R RubinAndrea PalermoPeter SchwarzClaudia GagnonElena TsourdiCarol ZhaoMichael A MakaraMichael S OminskyBryant LaiJenny UkenaChristopher T SibleyAimee D ShuPublished in: Advances in therapy (2024)
ClinicalTrials.gov NCT04701203.